SHCS Swiss HIV Cohort Study
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard H, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stoeckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso R, Andre P, Girardin F, Guidi M, Buclin T, Decosterd L, Swiss HIV Cohort Study S. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. Lancet Reg Health Eur 2023; 36:100793.
13.12.2023Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
13.12.2023Lancet Reg Health Eur 2023; 36:100793
Thoueille Paul, Alves Saldanha Susana, Schaller Fabian, Choong Eva, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldyrich F, Kusejko Katharina, Surial Bernard, Furrer Hansjakob, Rauch Andri, Rougemont Mathieu, Ustero Pilar, Calmy Alexandra, Stoeckle Marcel, Marzolini Catia, Di Benedetto Caroline, Bernasconi Enos, Schmid Patrick, Piso Rein Jan, Andre Pascal, Girardin François R, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Swiss HIV Cohort Study SHCS
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
Schwenke J, Thorball C, Schoepf I, Ryom L, Hasse B, Lamy O, Calmy A, Wandeler G, Marzolini C, Kahlert C, Bernasconi E, Kouyos R, Günthard H, Ledergerber B, Fellay J, Burkhalter F, Tarr P, Swiss HIV Cohort Study S. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study. J Infect Dis 2023; 228:742-750.
15.09.2023Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
15.09.2023J Infect Dis 2023; 228:742-750
Schwenke Johannes M, Thorball Christian Wandell, Schoepf Isabella C, Ryom Lene, Hasse Barbara, Lamy Olivier, Calmy Alexandra, Wandeler Gilles, Marzolini Catia, Kahlert Christian, Bernasconi Enos, Kouyos Roger D, Günthard Huldyrich F, Ledergerber Bruno, Fellay Jacques, Burkhalter Felix, Tarr Philip X00a0 E, Swiss HIV Cohort Study SHCS
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M, Frossard J, Kouyos R, Prendki V, Damas J, Hofmann E, Braun D, Schmid P, Bernasconi E, Ragozzino S, Efthimiou O, Delpierre C, Allavena C, Bani-Sadr F, Calmy A, Swiss HIV Cohort Study S. External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older. HIV Med 2023; 25:72-82.
24.08.2023External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
24.08.2023HIV Med 2023; 25:72-82
Hentzien Maxime, Frossard Jaromil, Kouyos Roger D, Prendki Virginie, Damas José, Hofmann Eveline, Braun Dominique, Schmid Patrick, Bernasconi Enos, Ragozzino Silvio, Efthimiou Orestis, Delpierre Cyrille, Allavena Clotilde, Bani-Sadr Firouzé, Calmy Alexandra, Swiss HIV Cohort Study SHCS
Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
Zeeb M, Tepekule B, Kusejko K, Reiber C, Kaelin M, Bartl L, Notter J, Furrer H, Hoffmann M, Hirsch H, Calmy A, Cavassini M, Labhardt N, Bernasconi E, Braun D, Günthard H, Kouyos R, Nemeth J, Swiss HIV Cohort Study S. Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland. Clin Infect Dis 2023
31.05.2023Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
31.05.2023Clin Infect Dis 2023
Zeeb Marius, Tepekule Burcu, Kusejko Katharina, Reiber Claudine, Kaelin Marisa B, Bartl Lena, Notter Julia, Furrer Hansjakob, Hoffmann Matthias, Hirsch Hans H., Calmy Alexandra, Cavassini Matthias, Labhardt Niklaus D, Bernasconi Enos, Braun Dominique Laurent, Günthard Huldyrich F, Kouyos Roger D, Nemeth Johannes, Swiss HIV Cohort Study SHCS
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen.
Marzolini C, Cavassini M, Braun D, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Elzi L, Swiss HIV Cohort Study S. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen. Br J Clin Pharmacol 2023
26.04.2023Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen.
26.04.2023Br J Clin Pharmacol 2023
Marzolini Catia, Cavassini Matthias, Braun Dominique Laurent, Hachfeld Anna, Bernasconi Enos, Calmy Alexandra, Schmid Patrick, Battegay Manuel, Elzi Luigia, Swiss HIV Cohort Study SHCS
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
Rohrbach J, Rauch A, Klenerman P, Furrer H, Battegay M, Bernasconi E, Hoffmann M, Hirschel B, Günthard H, Keiser O, Telenti A, Gorgievski M, Gaudieri S, Hammond E, Harcourt G, Robinson N, Swiss HIV Cohort Study S. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010; 59:1252-1258.
26.07.2010Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
26.07.2010Gut 2010; 59:1252-1258
Rohrbach Janine, Rauch Andri, Klenerman Paul, Furrer Hansjakob, Battegay Manuel, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernhard, Günthard Huldrych F, Keiser Olivia, Telenti Amalio, Gorgievski Meri, Gaudieri Silvana, Hammond Emma, Harcourt Gillian, Robinson Nicola, Swiss HIV Cohort Study SHCS